About NanoVation Therapeutics
Delivering tomorrow's genetic medicines, today™
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Vancouver, British Columbia
- Founded
- 2020
- Company type
- Privately Held
- Company profile name
- NanoVation Therapeutics™
NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery).
NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies.
NanoVation partners with leading pharmaceutical and biotech companies develop genetic medicines for previously untreatable diseases. NVTx is delivering tomorrow's genetic medicines, today.
For more information, please visit nanovationtx.com.
Specialties
- lipid nanoparticles
Company locations
2665 East Mall, Vancouver, British Columbia V6T 1Z4, CA
Locations on the company profile may be outside this area. Not every location is hiring.
Business areas
- Biotechnology
- Nanotechnology
- Therapeutics
On LinkedIn
- Followers
- 13,087
- People linked to this company
- 43
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
300,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.